345
Contents of Volume 13 Theme Title: THE ORAL CAVITY AS A SITE FOR DRUG DELIVERY PART II
Pre[ace M.J. Rathbone, B.K. Drummond and I.G. Tucker (New...
Contents of Volume 13 Theme Title: THE ORAL CAVITY AS A SITE FOR DRUG DELIVERY PART II
Pre[ace M.J. Rathbone, B.K. Drummond and I.G. Tucker (New Zealand) The oral cavity as a site for systemic drug delivery J.A. Weatherell, C. Robinson and M.J. Rathbone (UK, New Zealand) Site-specific differences in the salivary concentrations of substances in the oral cavity implications for the aetiology of oral disease and local drug delivery R.B. Gandhi and J.R. Robinson (USA) Oral cavity as a site for bioadhesive drug delivery G. Ponchel (France) Formulation of oral mucosal drug delivery systems for the systemic delivery of bioactive materials M.R. Rassing (Denmark) Chewing gum as a drug delivery system M. Addy (UK) Local delivery of antimicrobial agents to the oral cavity D.N. Thorburn and M.M. Ferguson (New Zealand) Topical corticosteroids and lesions of the oral mucosa M.M. Ferguson and M.J. Barker (New Zealand) Saliva substitutes in the management of salivary gland dysfunction L.P. Samaranayake and M.M. Ferguson (Hong Kong, New Zealand) Delivery of antifungal agents to the oral cavity N.J. Medlicott, M.J. Rathbone, 1.G. Tucker and D.W. Holborow (New Zealand) Delivery systems for the administration of drugs to the periodontal pocket
Theme Title: GLYCOLIPIDS IN DRUG DELIVERY K. Petrak (USA) Introduction Physico-chemical basis of specific interactions involving carbohydrates M.N. Jones (UK) Carbohydrate-mediated liposomal targeting and drug delivery R.B. Parekh (UK) Site-specific protein glycosylation G. Magnusson (Sweden) Synthesis of glycosphingolipids and corresponding neoglycolipids T.M. Allen (Canada) The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system E. Palomino (USA) 'Carbohydrate handles' as natural resources in drug delivery I.J. Fidler and E.S. Kleinerman (USA) Clinical application of phospholipid liposomes containing macrophage activators for therapy of cancer metastasis